Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond
Peter Libby · Cells · 2021 · Review
Full textCC BY
15 papersQuestions on this topic
Peter Libby · Cells · 2021 · Review
Full textCC BY
Martyna Strzelec, Jan Detka, Patrycja Mieszczak et al. · Frontiers in Immunology · 2023 · Review
Full textCC BY
Jeonghan Kim, Ho-Shik Kim, Jay H. Chung · Experimental & Molecular Medicine · 2023 · Review
Full textCC BY
Grith L. Sorensen · Frontiers in Medicine · 2018 · Review
Full textCC BY
Smita S. Chandran, Jiaqi Ma, Martin G. Klatt et al. · Nature Medicine · 2022
Full textCC BY
Qiang Zhou, Rui-Qing Peng, Xiao-Jun Wu et al. · Journal of Translational Medicine · 2010
Full textCC BY
Tobias Schwerd, Stephen R.F. Twigg, Dominik Aschenbrenner et al. · Journal of Experimental Medicine · 2017
Full textCC BY
Renée Bouwstra, Tom van Meerten, Edwin Bremer · Clinical and Translational Medicine · 2022 · Review
Full textCC BY
Andrew X. Chen, Robyn D. Gartrell, Junfei Zhao et al. · Genome Medicine · 2021
Full textCC BY
Yixin Li, Roger J Kurlander · Journal of Translational Medicine · 2010
Full textCC BY
Jeonghyun Ahn, Glen N. Barber · Experimental & Molecular Medicine · 2019 · Review
Full textCC BY
Alexander J. Clarke, Thomas Riffelmacher, Daniel Braas et al. · Journal of Experimental Medicine · 2018
Full textCC BY
Ilseon Hwang, Jeong Won Kim, Kris Ylaya et al. · Journal of Translational Medicine · 2020
Full textCC BY
Yun Zhou, Ke‐Ting Que, Zhen Zhang et al. · Cancer Medicine · 2018
Full textCC BY
Evangelos Andreakos, Sotirios Tsiodras · EMBO Molecular Medicine · 2020
Full textCC BY